84-3389-84 [取扱停止]Toso, CT (Regulator of Fas-induced Apoptosis, Fas Apoptotic Inhibitory Molecule 3, FAIM3) (AP) 100ul T8067-50C-AP
特徴
- Toso, also known as Fas Apoptotic Inhibitory Molecule 3 (FAIM3).
- Toso is expressed by lymphoid and hematopoietic cells and is up-regulated by T-cell activation.
- Toso expressing cells have increased resistance to Fas-, FADD-, and TNFalpha-induced apoptosis.
- Toso is membrane bound, and is thought to directly bind to FADD, disrupting DISC formation and thus inhibiting caspase-8 activation.
- Toso is a potential proto-oncogene, and could be a therapeutic target for use in the treatment of autoimmune diseases.
- Despite its predicted molecular weight, Toso often migrates at 60kD in SDS PAGE.
- Applications:Suitable for use in Western Blot.
- Other applications not tested.
- Recommended Dilution:Western Blot: 1-2ug/ml detects a band of ~43kD in human lung tissue lysate
- Optimal dilutions to be determined by the researcher.
- Storage and Stability:Store product at 4°C.
- DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid.
- Dilute required amount only prior to immediate use.
- Further dilutions can be made in assay buffer.
- For maximum recovery of product, centrifuge the original vial prior to removing the cap.
- Note: Applications are based on unconjugated antibody.
仕様
- Size:100ul
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by immunoaffinity chromatography.
- Form:Supplied as a liquid in PBS, pH 7.2. Labeled with Alkaline Phosphatase.
- Specificity:Recognizes an epitope within the C-terminal region of human Toso. Species sequence homology: mouse, rat.
- Isotype:IgG
- Calc Applications Abbrev:WB
- Calc Crossreactivity:Hu
- Immunogen:A 13aa peptide from near the carboxy terminus of human Toso.
- Shelf Life:1year
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]